When it comes to Alzheimer’s disease, what is the amyloid cascade hypothesis? How has this theory impacted drug development for Alzheimer’s disease over the past three decades?

With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on Alzheimer’s disease, the amyloid hypothesis, disease modification, and breakthroughs in diagnosis and treatment.

Today, Dr. Andy Cutler interviews Dr. Stephen Stahl on the current state of Alzheimer’s disease and the amyloid controversy.

Let’s listen in to Part 1 of our theme: Alzheimer’s Disease and the Amyloid Controversy

Subscribe to the NEI Podcast, so that you don’t miss another episode!

E173 - The PsychopharmaStahlogy Show: Alzheimer’s Disease and the Amyloid Controversy 48:59 Share

NEI Podcast

Shownotes Transcript

E173 - The PsychopharmaStahlogy Show: Alzheimer’s Disease and the Amyloid Controversy